Rankings
▼
Calendar
SION Q4 2023 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SION
Sionna Therapeutics, Inc.
$2B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$12M
EPS (Diluted)
$-0.27
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$8M
Stock-Based Comp.
$572,000
Balance Sheet
Total Assets
$52M
Total Liabilities
$167M
Stockholders' Equity
-$115M
Cash & Equivalents
$39M
← FY 2023
All Quarters
Q1 2024 →